News

All | 2019 | 2018 | 2017 | 2016

Hepatitis Goes Undiagnosed in Cancer Patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show that an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but... Read More

POSTED: 01/17/2019

Portrait of Scott Ramsey, MD, PhD

For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target

A new study has identified a potential biomarker of early-stage non–small cell lung cancer (NSCLC). The biomarker could help diagnose precancerous lung growths (called nodules or lesions) and early-stage lung cancers... Read More

POSTED: 01/03/2019

Imaging scans identified a lung nodule (panels A and B) which, over the course of 11 months progressed (panels C and D) and, following a biopsy, was confirmed as lung cancer.

The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool

Last month, I released a report to the White House and the public, HPV Vaccination for Cancer Prevention: Progress, Opportunities, and a Renewed Call to Action. This report describes the progress that’s been made toward... Read More

POSTED: 12/20/2018

Vitamin D Supplements Don’t Reduce Cancer Incidence, Trial Shows

In the largest-ever randomized clinical trial testing vitamin D for cancer prevention, the supplement did not reduce the risk of developing cancer. A large body of epidemiology research had suggested that people with higher... Read More

POSTED: 12/13/2018

Self-described “big fan” of the NCI Community Oncology Research Program (NCORP), NCI Director Norman (Ned) Sharpless, MD, welcomed investigators and administrators from the program to their annual meeting in late September... Read More

POSTED: 11/08/2018

NCI Director Norman (Ned) Sharpless welcoming investigators and administrators from the program to their annual meeting in late September in Bethesda, Maryland.

Dear Colleague, The fall issue of Nutrition Frontiers celebrates October’s Breast Cancer Awareness Month and showcases breast cancer research, including modifiable diet quality, prevention of breast cancer induced... Read More

POSTED: 10/30/2018

NCI Summer Curriculum: Strengthening Global Cancer Research Capacity

Every year, the Cancer Prevention Fellowship Program (CPFP) hosts the NCI Summer Curriculum featuring two courses: The Principles and Practice of Cancer Prevention and Control (PPCPC) and the Molecular Prevention Course. The... Read More

POSTED: 10/30/2018

Group photo of the 2018 CPFP Summer Curriculum participants.

Through research, interventions and actions have been shown to reduce risk for a wide variety of cancers. This infographic highlights six categories of actions that may help prevent cancer. Infographic Highlight Cancer... Read More

POSTED: 10/15/2018

Cancer prevention interventions available today include: medications, lifestyle choices, treatments for infections, screening tests, vaccines, and surgery.

The National Cancer Institute issued two funding opportunityannouncements to create a grant-funded network for early phase cancer prevention trials. Requests for Applications for the Cancer Prevention Clinical Trials... Read More

POSTED: 09/25/2018

Image of a daughter accompanying her father during a consultation with a physician.

Heart Problems: Investigating the Cardiac Side Effects of Cancer Treatments

In June, approximately 100 researchers attended a workshop on the campus of the National Institutes of Health (NIH) in Bethesda, MD, about an important but underappreciated side effect of some treatments for cancer: heart... Read More

POSTED: 09/21/2018

Daily Low-dose Aspirin Found to Have No Effect on Healthy Life Span in Older People

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of... Read More

POSTED: 09/16/2018

Pile of pills aspirin

Integrating Geriatric Assessment into Cancer Care: A Conversation with Dr. Supriya Mohile

More than 60% of patients with cancer are age 65 and over. Despite the relatively high prevalence of cancer in older adults, there is a gap in knowledge about the safest and most effective cancer treatments for patients in... Read More

POSTED: 09/11/2018

Access to Care May Reduce Cancer Disparities

When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show. The study results are published in JAMA Network Open by a team... Read More

POSTED: 08/17/2018

Portrait of Joesph Unger, PhD

Dear Colleague, The summer issue of Nutrition Frontiers showcases vitamin D-related genetic variation and cancer risk, the therapeutic potential of zerumbone, a ginger extract, against hepatocellular cancer, and the... Read More

POSTED: 08/02/2018

A collection of foods high in Vitamin D.

The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr. Judith Paice

Pain is a common symptom in cancer patients. It can be caused by cancer, its treatments, or a combination of factors. Although some pain lasts a relatively short time and will resolve on its own, cancer or its treatments can... Read More

POSTED: 07/16/2018

Judith Paice, Ph.D., R.N., director of the Cancer Pain Program, Northwestern University Feinberg School of Medicine.

NCI and VA collaborate to boost veterans’ access to cancer clinical trials

Veterans with cancer who receive treatment from the Department of Veterans Affairs (VA) will now have easier access to clinical trials of novel cancer treatments, thanks to an agreement between VA and the National Cancer... Read More

POSTED: 07/10/2018

Map of the United States displaying the NAVIGATE sites.

Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents

Health care providers should emphasize cancer prevention when discussing human papillomavirus (HPV) vaccination with the parents of preteens who are due to receive the vaccine. That’s the conclusion of a new study that asked... Read More

POSTED: 07/10/2018

The NCI Community Oncology Research Program (NCORP) issued three funding opportunity announcements; one each for Community Sites, Minority/Underserved Community Sites, and Research Bases. In addition, the program announced... Read More

POSTED: 06/25/2018

NCI Community Oncology Research Program (NCORP)

Finasteride Safe, Long-Term Results Show

Twenty five years after it opened for enrollment, the landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer... Read More

POSTED: 05/21/2018

Dear Colleague, The spring issue of Nutrition Frontiers showcases the association of gut microbial communities in premenopausal women, how high-fat, high-calorie-diet-induced obesity may increase pancreatic cancer, and the... Read More

POSTED: 05/14/2018

A illustration displaying gut microbial.

The NCI Cancer Prevention Fellowship Program (CPFP), which supports postdoctoral research and leadership training, is accepting applications for the fellows’ class that starts in 2019. The application period is open until... Read More

POSTED: 05/10/2018

A photo of CPFP fellows at the NCI Shady Grove campus.

Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers

Researchers have shown that an experimental screening test can detect some endometrial and ovarian cancers at their early, more treatable stages. The test, called PapSEEK, is a type of liquid biopsy that identifies cancer-... Read More

POSTED: 05/02/2018

PapSEEK detects genetic alterations in DNA that ovarian and endometrial tumors have shed into the uterus, cervix, and blood (plasma).

Division of Cancer Prevention Director Barry Kramer, MD, MPH, answers questions about cancer overdiagnosis. Q: What is cancer overdiagnosis? A: Cancer overdiagnosis is the detection of asymptomatic cancers, often through... Read More

POSTED: 04/23/2018

Partial thumbnail of the 'What is Cancer Overdiagnosis?' infographic.

The Finding Cancer Trials Collaborative

Imagine a day when a cancer patient can find relevant cancer clinical trials with ease. We invite the entire cancer community – including patients, advocates, clinical trialists, industry, and NCI – to achieve this vision... Read More

POSTED: 04/16/2018

Finding Cancer Trials Collaborative

The PREVENT Cancer Preclinical Drug Development Program (PREVENT) is a peer-reviewed program designed to support development of the best ideas in cancer prevention using National Cancer Institute contract resources. The... Read More

POSTED: 04/13/2018

Pages